Overexpression of the receptor tyrosine kinase Axl has been involved in resistance to BYL719 in head and neck squamous cell carcinoma (HNSCC) and esophageal squamous cell carcinoma (ESCC) [62]. This evidence concerns the gene NTRK1 and head and neck squamous cell carcinoma.